
Molecule: CANAKINUMAB
ChEMBL ID: CHEMBL1201834
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2009

Molecule: RILONACEPT
ChEMBL ID: CHEMBL1201830
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2008

Molecule: GEVOKIZUMAB
ChEMBL ID: CHEMBL1743026
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: CDP-484
ChEMBL ID: CHEMBL2109459
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: LUTIKIZUMAB
ChEMBL ID: CHEMBL4594518
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
